Lakefront Biotherapeutics (LKFT) Cash from Investing Activities (QoQ) (2016 - 2026)
Lakefront Biotherapeutics (LKFT) Cash from Investing Activities (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Lakefront Biotherapeutics | 1.86 Bn | -1.54 Bn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.32% |
| Mar 31, 2025 | 23.97% |
| Mar 31, 2024 | -61.18% |
| Mar 31, 2023 | -1,693.89% |
| Jun 30, 2020 | -123.32% |
| Mar 31, 2020 | 124.84% |
| Dec 31, 2019 | -26,213.50% |
| Sep 30, 2019 | -170.19% |
| Jun 30, 2019 | -54.89% |
| Mar 31, 2019 | 66.87% |
| Dec 31, 2018 | -318.39% |
| Sep 30, 2018 | 11.86% |
| Jun 30, 2018 | -43.24% |
| Mar 31, 2018 | -127.85% |
| Dec 31, 2017 | 100.12% |
| Sep 30, 2017 | -200.04% |
| Jun 30, 2017 | 80,771.44% |
| Jun 30, 2016 | -88.19% |
| Mar 31, 2016 | 75.56% |